Myelodysplastic syndromes trials in Puerto Rico

In Puerto Rico 5 Also abroad 369

5 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Where
San Juan
Age
18 years to 59 years
People
335 worldwide
Run by
National Cancer Institute (NCI)
See details and how to joinNCT05554406
Phase 2Taking people
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
Where
San Juan
Age
18 years and over
People
54 worldwide
Run by
National Cancer Institute (NCI)
See details and how to joinNCT06577441
Phase 2Taking people
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Where
San Juan
Age
18 years and over
People
2,000 worldwide
Run by
National Cancer Institute (NCI)
See details and how to joinNCT05564390
Phase 1/2Taking people
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Where
Caguas, San Juan
Age
Up to 22 years
People
960 worldwide
Run by
PedAL BCU, LLC
See details and how to joinNCT04726241
No phaseTaking people
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Where
San Juan
People
50,000 worldwide
Run by
Massive Bio, Inc.
See details and how to joinNCT03452774